Kilitch Drugs India Limited announced earnings results for the fourth quarter ended March 31, 2021. For the fourth quarter, the company announced total revenue was INR 214.393 million compared to INR 130.947 million a year ago. Net income was INR 7.085 million compared to net loss of INR 12.472 million a year ago. Basic earnings per share from continuing operations was INR 0.46 compared to basic loss per share from continuing operations of INR 0.81 a year ago. For the full year, total revenue was INR 711.904 million compared to INR 574.455 million a year ago. Net income was INR 36.711 million compared to INR 8.42 million a year ago. Basic earnings per share from continuing operations was INR 2.37 compared to INR 0.55 a year ago.